Literature DB >> 2647040

Acute effects of instillation of surfactant in severe respiratory distress syndrome.

H L Halliday1, F B McCord, B G McClure, M M Reid.   

Abstract

Doppler ultrasound measurements of pulmonary blood flow in 20 babies with severe respiratory distress syndrome treated in a randomised controlled trial of surfactant replacement showed that the immediate improvement of oxygenation was not associated with a significant increase in pulmonary blood flow. Reduction in ventilator settings and increases in the extent of chest wall movements measured by a cardiorespiratory monitor suggested that the improvement after surfactant had been given was a result of alveolar stabilisation and increased pulmonary compliance. Further simultaneous studies of pulmonary blood flow and pulmonary compliance are needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647040      PMCID: PMC1590071          DOI: 10.1136/adc.64.1_spec_no.13

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Confidence intervals rather than P values: estimation rather than hypothesis testing.

Authors:  M J Gardner; D G Altman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

2.  Transthoracic impedance, with special reference to newborn infants and the ratio air-to-fluid in the lungs.

Authors:  T Olsson; L Victorin
Journal:  Acta Paediatr Scand Suppl       Date:  1970

3.  Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant.

Authors:  A Jobe; M Ikegami; H Jacobs; S Jones
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

4.  Noninvasive pulsed Doppler determination of cardiac output in neonates and children.

Authors:  D C Alverson; M Eldridge; T Dillon; S M Yabek; W Berman
Journal:  J Pediatr       Date:  1982-07       Impact factor: 4.406

5.  Cardiovascular effects of surfactant suspensions given by tracheal instillation to premature lambs.

Authors:  A Jobe; H Jacobs; M Ikegami; S Jones
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

6.  Premature lambs rescued from respiratory failure with natural surfactant: clinical and biophysical correlates.

Authors:  H Jacobs; A Jobe; M Ikegami; T Glatz; S J Jones; L Barajas
Journal:  Pediatr Res       Date:  1982-06       Impact factor: 3.756

7.  Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.

Authors:  D Vidyasagar; H Maeta; T N Raju; E John; R Bhat; M Go; U Dahiya; Y Roberson; A Yamin; A Narula
Journal:  Pediatrics       Date:  1985-06       Impact factor: 7.124

8.  The relationship between PaCO2 and ventilation parameters in predicting survival in congenital diaphragmatic hernia.

Authors:  D J Bohn; I James; R M Filler; S H Ein; D E Wesson; B Shandling; C Stephens; G A Barker
Journal:  J Pediatr Surg       Date:  1984-12       Impact factor: 2.545

9.  Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.

Authors:  G Noack; P Berggren; T Curstedt; G Grossmann; P Herin; W Mortensson; R Nilsson; B Robertson
Journal:  Acta Paediatr Scand       Date:  1987-09

10.  Duration and characteristics of treatment of premature lambs with natural surfactant.

Authors:  A Jobe; M Ikegami; T Glatz; Y Yoshida; E Diakomanolis; J Padbury
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

View more
  11 in total

1.  Cerebral blood flow velocity changes after rapid administration of surfactant.

Authors:  F Cowan; A Whitelaw; D Wertheim; M Silverman
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

2.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

3.  Surfactant and patent ductus arteriosus.

Authors:  Abhay Kumar; Anil Lakkundi; Patrick J McNamara; Arvind Sehgal
Journal:  Indian J Pediatr       Date:  2010-01-20       Impact factor: 1.967

4.  Lung volume and pulmonary blood flow measurements following exogenous surfactant.

Authors:  J Alexander; A D Milner
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

Review 5.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

6.  The effects of surfactant on haemodynamics in hyaline membrane disease.

Authors:  J Skinner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

7.  How does exogenous surfactant really work?

Authors:  A D Milner
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

8.  Changes in oxygenation and heart rate after administration of artificial surfactant (ALEC) to preterm infants.

Authors:  J S Ahluwalia; C J Morley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

9.  How does exogenous surfactant work?

Authors:  A D Milner
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

10.  Surfactant treatment for respiratory distress syndrome following prolonged rupture of membranes.

Authors:  T R Tubman; H L Halliday
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.